查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1489263

全球電腦模擬藥物發現市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global In-Silico Drug Discovery Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2032年，全球電腦模擬藥物發現市場的市場規模將從2023年的30.997億美元達到近83.3005億美元，2024-2032年研究期間的複合年成長率為11.61%。

電腦模擬藥物發現涉及使用電腦模擬和計算方法來識別和開發新藥物。此方法利用生物資訊學、分子建模和資料分析來預測候選藥物如何與生物標靶相互作用。電腦技術可以篩選大量的化合物庫，識別潛在的候選藥物，最佳化先導化合物，並預測其藥物動力學和毒理學特徵。這種方法顯著加速了藥物發現過程，降低了成本，並最大限度地減少了大量實驗室工作的需要。

市場動態

電腦模擬藥物發現市場是由對更有效率、更具成本效益和更快的藥物發現過程的需求所推動的。計算生物學和生物資訊學的進步顯著增強了電腦模擬藥物發現的能力，使研究人員能夠預測藥物交互作用、最佳化候選藥物並在開發早期識別潛在的副作用。傳統藥物開發成本的不斷上升以及針對多因素疾病的複雜性日益增加，使得 In-Silico 方法更具吸引力。此外，對將計算方法整合到藥物開發過程中的監管支持鼓勵更多的製藥公司採用這些技術。高效能運算資源和複雜軟體工具的不斷增加進一步推動了電腦模擬藥物發現市場的成長。然而，計算複雜性和資料準確性問題可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球電腦藥物發現市場的每個細分市場進行了包容性評估。電腦模擬藥物發現產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

電腦模擬藥物發現市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 軟體作為服務
  • 軟體
  • 諮詢即服務

按工作流程

  • 臨床前測試
  • 發現
  • 臨床測試

按目標治療領域

  • 代謝紊亂
  • 愛滋病
  • 傳染性疾病
  • 肌肉骨骼疾病
  • 精神錯亂
  • 神經系統疾病
  • 腫瘤疾病

按最終用戶

  • 合約研究組織
  • 製藥和生物製藥公司
  • 學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的電腦模擬藥物發現市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。電腦模擬藥物發現市場的主要參與者包括 Charles River Laboratories、Curia Global Inc.（美國 Certara）、Chemical Computer Group ULC、GenScript、Sygnature Discovery、Abzena Ltd.、BioNTech SE、Creative Biostruct。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：電腦模擬藥物發現 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 依工作流程進行市場吸引力分析
    • 按目標治療領域分類的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球電腦模擬藥物發現市場分析：按產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 軟體作為服務
  • 軟體
  • 諮詢即服務

第 6 章：全球電腦模擬藥物發現市場分析：按工作流程

  • 按工作流程概述
  • 按工作流程進行歷史和預測資料分析
  • 臨床前測試
  • 發現
  • 臨床測試

第 7 章：全球電腦模擬藥物發現市場分析：按目標治療領域

  • 按目標治療領域概述
  • 按目標治療領域進行的歷史和預測數據分析
  • 代謝紊亂
  • 愛滋病
  • 傳染性疾病
  • 肌肉骨骼疾病
  • 精神錯亂
  • 神經系統疾病
  • 腫瘤疾病

第 8 章：全球電腦模擬藥物發現市場分析：按最終用戶分類

  • 最終用戶概述
  • 最終用戶的歷史和預測數據分析
  • 合約研究組織
  • 製藥和生物製藥公司
  • 學術及研究機構

第 9 章：全球電腦模擬藥物發現市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：電腦模擬藥物發現公司的競爭格局

  • 電腦模擬藥物發現市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Charles River Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Curia Global Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Certara USA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Creative Biostructure
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Chemical Computing Group ULC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GenScript
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sygnature Discovery
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abzena Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioNTech SE
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114720

The global demand for In-Silico Drug Discovery Market is presumed to reach the market size of nearly USD 8330.05 Million by 2032 from USD 3099.7 Million in 2023 with a CAGR of 11.61% under the study period 2024-2032.

In-silico drug discovery involves using computer simulations and computational methods to identify and develop new pharmaceuticals. This approach utilizes bioinformatics, molecular modeling, and data analysis to predict how drug candidates interact with biological targets. In-silico techniques can screen vast libraries of compounds, identify potential drug candidates, optimize lead compounds, and predict their pharmacokinetic and toxicological profiles. This method significantly accelerates the drug discovery process, reduces costs, and minimizes the need for extensive laboratory work.

MARKET DYNAMICS

The in-silico drug discovery market is driven by the need for more efficient, cost-effective, and faster drug discovery processes. Advances in computational biology and bioinformatics have significantly enhanced the capabilities of in-silico drug discovery, enabling researchers to predict drug interactions, optimize drug candidates, and identify potential side effects early in development. The rising cost of traditional drug development and the increasing complexity of targeting multifactorial diseases make In-Silico approaches more attractive. Additionally, regulatory support for integrating computational methods in drug development processes encourages more pharmaceutical companies to adopt these technologies. The growing availability of high-performance computing resources and sophisticated software tools further propels the growth of the in-silico drug discovery market. However, computational complexities and data accuracy concerns may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In-Silico Drug Discovery. The growth and trends of In-Silico Drug Discovery industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In-Silico Drug Discovery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Software-as-a-Service
  • Software
  • Consultancy-as-a-Service

By Workflow

  • Pre-Clinical Tests
  • Discovery
  • Clinical Tests

By Target Therapeutic Area

  • Metabolic disorders
  • HIV
  • Infectious diseases
  • Musculoskeletal disorders
  • Mental disorders
  • Neurological disorders
  • Oncological disorders

By End User

  • Contract Research Organizations
  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In-Silico Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In-Silico Drug Discovery market include Charles River Laboratories, Curia Global Inc., Certara, USA, Chemical Computing Group ULC, GenScript, Sygnature Discovery, Abzena Ltd., BioNTech SE, Creative Biostructure. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN-SILICO DRUG DISCOVERY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Target Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Software-as-a-Service Historic and Forecast Sales By Regions
  • 5.4. Software Historic and Forecast Sales By Regions
  • 5.5. Consultancy-as-a-Service Historic and Forecast Sales By Regions

6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data Analysis By Workflow
  • 6.3. Pre-Clinical Tests Historic and Forecast Sales By Regions
  • 6.4. Discovery Historic and Forecast Sales By Regions
  • 6.5. Clinical Tests Historic and Forecast Sales By Regions

7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY TARGET THERAPEUTIC AREA

  • 7.1. Overview By Target Therapeutic Area
  • 7.2. Historical and Forecast Data Analysis By Target Therapeutic Area
  • 7.3. Metabolic disorders Historic and Forecast Sales By Regions
  • 7.4. HIV Historic and Forecast Sales By Regions
  • 7.5. Infectious diseases Historic and Forecast Sales By Regions
  • 7.6. Musculoskeletal disorders Historic and Forecast Sales By Regions
  • 7.7. Mental disorders Historic and Forecast Sales By Regions
  • 7.8. Neurological disorders Historic and Forecast Sales By Regions
  • 7.9. Oncological disorders Historic and Forecast Sales By Regions

8. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Contract Research Organizations Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical and Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN-SILICO DRUG DISCOVERY COMPANIES

  • 10.1. In-Silico Drug Discovery Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF IN-SILICO DRUG DISCOVERY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Charles River Laboratories
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Curia Global Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Certara USA
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Creative Biostructure
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Chemical Computing Group ULC
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. GenScript
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Sygnature Discovery
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Abzena Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BioNTech SE
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global In-Silico Drug Discovery Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In-Silico Drug Discovery Report
  • Market Research Process
  • Market Research Methodology
  • Global In-Silico Drug Discovery Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Target Therapeutic Area
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Global Market Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.